Loading icon
Categories
Bioinformatics
2
Genetics
10
Art and Literature
3
Tutorials
6
Multiple Sclerosis
5
Omics
2
Trending post
1
Plasma Lipids, Statin Biology, and Multiple Sclerosis: Mendelian Randomization Evidence for Cholesterol-Independent Mechanisms
Genetics
Plasma Lipids, Statin Biology, and Multiple Sclerosis: Mendelian Randomization Evidence for Cholesterol-Independent Mechanisms

20, Dec 2025

2
Plasma Lipids, Statin Biology, and Multiple Sclerosis: Mendelian Randomization Evidence for Cholesterol-Independent Mechanisms
Genetics
Lipid Genetics and Disability Progression in Multiple Sclerosis: Evidence for Risk-Allele–Dependent Effects of HDL and Cholesterol Balance

19, Dec 2025

3
Deep Genomic History and the Evolutionary Origins of Multiple Sclerosis Risk
Genetics
Deep Genomic History and the Evolutionary Origins of Multiple Sclerosis Risk

19, Dec 2025

4
Inside the MS Risk Blueprint: Pinpointing the Immune Cells and Brain Microglia Where Genetics Hits
Genetics
Inside the MS Risk Blueprint: Pinpointing the Immune Cells and Brain Microglia Where Genetics Hits

18, Dec 2025

5
The MS Risk You’re Born With: T-Cell Fingerprint Hidden in Our Genes
Genetics
The MS Risk You’re Born With: T-Cell Fingerprint Hidden in Our Genes

17, Dec 2025

Categories:
Genetics
Understanding the Role of NDFIP1 in Multiple Sclerosis: A Dive into Genetic Variation and Immune Cell Metabolism
Genetics
Understanding the Role of NDFIP1 in Multiple Sclerosis: A Dive into Genetic Variation and Immune Cell Metabolism

21, Jul 2024

Understanding the Role of Pharmacogenetics in Personalized Therapy for Multiple Sclerosis
Genetics
Understanding the Role of Pharmacogenetics in Personalized Therapy for Multiple Sclerosis

21, Jul 2024

Role of Methionine Metabolism in Multiple Sclerosis
Genetics
Role of Methionine Metabolism in Multiple Sclerosis

23, Jul 2024

How a Rare CYP2R1 Variant Influences Levels and Multiple Sclerosis Risk
Genetics
How a Rare CYP2R1 Variant Influences Levels and Multiple Sclerosis Risk

24, Jul 2024